Technical Analysis for BBLGW - Bone Biologics Corp - warrants
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| New 52 Week Closing High | Bullish | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 1.21% | |
| Narrow Range Bar | Range Contraction | 1.21% |
Free Daily (Stock) Chart Reading
- Earnings date: Unknown
Bone Biologics Corp - warrants Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Neurosurgical Procedures Spinal Fusion Applications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 46.8 |
| 52 Week Low | 0.4334 |
| Average Volume | 1,221 |
| 200-Day Moving Average | 9.84 |
| 50-Day Moving Average | 24.02 |
| 20-Day Moving Average | 32.90 |
| 10-Day Moving Average | 39.83 |
| Average True Range | 2.92 |
| RSI (14) | 71.83 |
| ADX | 22.97 |
| +DI | 48.49 |
| -DI | 31.09 |
| Chandelier Exit (Long, 3 ATRs) | 38.03 |
| Chandelier Exit (Short, 3 ATRs) | 27.78 |
| Upper Bollinger Bands | 49.80 |
| Lower Bollinger Band | 16.01 |
| Percent B (%b) | 0.81 |
| BandWidth | 102.68 |
| MACD Line | 6.34 |
| MACD Signal Line | 5.58 |
| MACD Histogram | 0.7625 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 43.50 | ||||
| Resistance 3 (R3) | 43.50 | 43.50 | 43.50 | ||
| Resistance 2 (R2) | 43.50 | 43.50 | 43.50 | 43.50 | |
| Resistance 1 (R1) | 43.50 | 43.50 | 43.50 | 43.50 | 43.50 |
| Pivot Point | 43.50 | 43.50 | 43.50 | 43.50 | 43.50 |
| Support 1 (S1) | 43.50 | 43.50 | 43.50 | 43.50 | 43.50 |
| Support 2 (S2) | 43.50 | 43.50 | 43.50 | 43.50 | |
| Support 3 (S3) | 43.50 | 43.50 | 43.50 | ||
| Support 4 (S4) | 43.50 |
